Macrogenics (MGNX) Assets Average (2013 - 2026)
Macrogenics (MGNX) reported Assets Average of $237.4 million for Q1 2026, down 2.37% year-over-year from $243.1 million in Q1 2025, and down 10.02% quarter-over-quarter from $263.8 million in Q4 2025.
Macrogenics (MGNX) Assets Average (2013 - 2026) Analysis & Trends
Macrogenics (MGNX) has 14 years of Assets Average data on file, last reported at $237.4 million in Q1 2026.
- Assets Average for Q1 2026 came in at $237.4 million, down 2.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $237.4 million (down 2.37% YoY), and the FY2025 annual result was $259.3 million, down 7.42% from the prior year.
- Assets Average eased to $237.4 million in Q1 2026 per MGNX's latest filing, from $263.8 million in the prior quarter.
- Over five years, Assets Average peaked at $324.6 million in Q2 2023 and troughed at $206.7 million in Q3 2022.
- A 5-year average of $264.9 million and a median of $258.1 million in 2025 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2023: Assets Average slumped 49.47% in 2022, then soared 56.18% in 2023.
- A 5-year view of Assets Average shows it stood at $237.9 million in 2022, then surged by 34.17% to $319.2 million in 2023, then retreated by 17.58% to $263.1 million in 2024, then gained by 0.28% to $263.8 million in 2025, then decreased by 10.02% to $237.4 million in 2026.
- Business Quant data shows MGNX's Assets Average at $237.4 million in Q1 2026, $263.8 million in Q4 2025, and $258.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | 237.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 237.36 Mn |
| Dec 31, 2025 | 263.80 Mn |
| Sep 30, 2025 | 258.09 Mn |
| Jun 30, 2025 | 234.99 Mn |
| Mar 31, 2025 | 243.11 Mn |
| Dec 31, 2024 | 263.07 Mn |
| Sep 30, 2024 | 232.81 Mn |
| Jun 30, 2024 | 224.71 Mn |
| Mar 31, 2024 | 273.35 Mn |
| Dec 31, 2023 | 319.20 Mn |
| Sep 30, 2023 | 322.81 Mn |
| Jun 30, 2023 | 324.58 Mn |
| Mar 31, 2023 | 311.98 Mn |
| Dec 31, 2022 | 237.91 Mn |
| Sep 30, 2022 | 206.70 Mn |
| Jun 30, 2022 | 244.74 Mn |
| Mar 31, 2022 | 303.35 Mn |
| Dec 31, 2021 | 363.70 Mn |
| Sep 30, 2021 | 409.04 Mn |
| Jun 30, 2021 | 430.68 Mn |